SICHUAN KELUN-BIOTECH BIOPHARMACEUTSICHUAN KELUN-BIOTECH BIOPHARMACEUTSICHUAN KELUN-BIOTECH BIOPHARMACEUT

SICHUAN KELUN-BIOTECH BIOPHARMACEUT

No trades
See on Supercharts

6990 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. It offers proprietary technology platforms focusing on the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancers, and colorectal cancer, as well as non-oncology diseases. The company was founded by Ge Xin Liu on November 22, 2016 and is headquartered in Chengdu, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6990 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company